Exploring Regional Insights and Opportunities in the Fc Fusion Protein Market
The global Fc fusion protein market size reached USD 26.97 Billion in 2020 and is expected to register a revenue CAGR of 10.5% during the forecast period, according to latest analysis by Emergen Research. Increased use of Fc fusion proteins for in vivo and in vitro research, as well as increased use as drugs are key factors expected to drive robust market revenue growth over the forecast period. Increasing use of Fc fusion protein for vaccines is also expected to contribute significantly to revenue growth of the market between 2021 and 2028. Vaccination is becoming more important as the prevalence of infectious diseases rises around the globe. Increased use of Fc fusion protein for vaccines such as Filovirus vaccines is expected to boost market growth going ahead. In rabbits, mice, and monkeys, the immunogenicity of a CHO-expressed recombinant SARS-CoV-2 S1-Fc fusion protein as a potential COVID-19 vaccine option was studied. The immunogenicity of the S1-Fc fusion protein is stro...